يعرض 1 - 10 نتائج من 18 نتيجة بحث عن '"deep vein thrombosis/di [Diagnosis]"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    مورد إلكتروني
  2. 2
  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: recurrence risk, risk factor, surgical thrombectomy, symptom, treatment duration, venous thromboembolism/di [Diagnosis], venous thromboembolism/dt [Drug Therapy], ventilation-perfusion scan, anticoagulant agent/do [Drug Dose], anticoagulant agent/dt [Drug Therapy], anticoagulant agent/po [Oral Drug Administration], apixaban/dt [Drug Therapy], apixaban/po [Oral Drug Administration], blood clotting factor 10a inhibitor/dt [Drug Therapy], D dimer/ec [Endogenous Compound], dabigatran/dt [Drug Therapy], dabigatran/po [Oral Drug Administration], dalteparin/dt [Drug Therapy], dalteparin/sc [Subcutaneous Drug Administration], edoxaban/dt [Drug Therapy], edoxaban/po [Oral Drug Administration], enoxaparin/dt [Drug Therapy], enoxaparin/sc [Subcutaneous Drug Administration], fibrinolytic agent/dt [Drug Therapy], rivaroxaban/dt [Drug Therapy], rivaroxaban/po [Oral Drug Administration], compression stocking, warfarin/dt [Drug Therapy], access to information, antiphospholipid syndrome, article, Australia and New Zealand, computer assisted tomography, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], deep vein thrombosis/th [Therapy], Doppler ultrasonography, human, incidence, Internet, low drug dose, lung angiography, lung embolism/di [Diagnosis], lung embolism/dt [Drug Therapy], lung embolism/su [Surgery], lung embolism/th [Therapy], malignant neoplasm, medical society, percutaneous thrombectomy, practice guideline, prescription, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35318Test
    Medical Journal of Australia
    Click here for full text options
    LibKey Link

  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: recurrence risk, risk factor, surgical thrombectomy, symptom, treatment duration, venous thromboembolism/di [Diagnosis], venous thromboembolism/dt [Drug Therapy], ventilation-perfusion scan, anticoagulant agent/do [Drug Dose], anticoagulant agent/dt [Drug Therapy], anticoagulant agent/po [Oral Drug Administration], apixaban/dt [Drug Therapy], apixaban/po [Oral Drug Administration], blood clotting factor 10a inhibitor/dt [Drug Therapy], D dimer/ec [Endogenous Compound], dabigatran/dt [Drug Therapy], dabigatran/po [Oral Drug Administration], dalteparin/dt [Drug Therapy], dalteparin/sc [Subcutaneous Drug Administration], edoxaban/dt [Drug Therapy], edoxaban/po [Oral Drug Administration], enoxaparin/dt [Drug Therapy], enoxaparin/sc [Subcutaneous Drug Administration], fibrinolytic agent/dt [Drug Therapy], rivaroxaban/dt [Drug Therapy], rivaroxaban/po [Oral Drug Administration], compression stocking, warfarin/dt [Drug Therapy], access to information, antiphospholipid syndrome, article, Australia and New Zealand, computer assisted tomography, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], deep vein thrombosis/th [Therapy], Doppler ultrasonography, human, incidence, Internet, low drug dose, lung angiography, lung embolism/di [Diagnosis], lung embolism/dt [Drug Therapy], lung embolism/su [Surgery], lung embolism/th [Therapy], malignant neoplasm, medical society, percutaneous thrombectomy, practice guideline, prescription, Article

  6. 6
    مورد إلكتروني

    مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
    Nephrology
    Click here for full text options
    LibKey Link

  7. 7
    مورد إلكتروني

    مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
    Nephrology
    Click here for full text options
    LibKey Link

  8. 8
  9. 9
  10. 10
    مورد إلكتروني